MyFinsight
Home
Blog
About
Proceeds from sale and
maturity of marketable...
$5,000K
Net cash provided by
investing activities
$5,000K
(decrease) increase in cash
and cash...
-$1,102K
Canceled cashflow
$5,000K
Stock-based compensation
$910K
Prepaid expenses and
other assets and...
-$462K
Depreciation
$12K
Net cash used in
operating activities
-$6,073K
Canceled cashflow
$1,384K
Net cash used in
financing activities
-$29K
Net loss
-$6,592K
Trade payables,
accrued expenses,...
-$844K
Amortization of premium or
discount on marketable...
-$21K
Withholdings from exercise of
options and issuance of...
-$29K
Loss from continuing
operations
-$6,484K
Loss from
discontinued operations, net...
-$108K
Other income, net
$434K
Loss from continuing
operations before income...
-$6,484K
Canceled cashflow
$434K
Royalty
revenues-Royalty
$183K
Operating loss
-$6,918K
Canceled cashflow
$183K
Total operating
expenses
$7,101K
General and
administrative
$5,496K
Other segment items
$821K
Research and
development-Research And Development...
$592K
Research and
development-Repibresib VYN201
$192K
Back
Back
Cash Flow
Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. (YARW)
source: myfinsight.com